SILVER STD RES INC's ticker is SSRI and the CUSIP is 82823L106. A total of 103 filers reported holding SILVER STD RES INC in Q1 2014. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $25,302,000 | +105.8% | 2,606,031 | +124.9% | 0.01% | +100.0% |
Q1 2017 | $12,292,000 | -1.5% | 1,158,787 | -17.1% | 0.01% | 0.0% |
Q4 2016 | $12,479,000 | -32.4% | 1,398,292 | -12.8% | 0.01% | -44.4% |
Q3 2016 | $18,464,000 | +9.8% | 1,603,338 | +23.8% | 0.01% | +12.5% |
Q2 2016 | $16,812,000 | +108.8% | 1,295,186 | -10.7% | 0.01% | +100.0% |
Q1 2016 | $8,051,000 | +7.3% | 1,449,588 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $7,505,000 | +4.1% | 1,449,588 | +31.0% | 0.00% | 0.0% |
Q3 2015 | $7,210,000 | -27.7% | 1,106,535 | -30.4% | 0.00% | -20.0% |
Q2 2015 | $9,979,000 | +1321.5% | 1,588,850 | +921.7% | 0.01% | – |
Q1 2015 | $702,000 | -28.9% | 155,517 | -20.7% | 0.00% | -100.0% |
Q4 2014 | $987,000 | -56.5% | 196,129 | -47.2% | 0.00% | 0.0% |
Q3 2014 | $2,270,000 | -64.7% | 371,462 | -50.0% | 0.00% | -50.0% |
Q2 2014 | $6,438,000 | +3.7% | 742,924 | +18.9% | 0.00% | -50.0% |
Q1 2014 | $6,208,000 | +43.3% | 624,586 | 0.0% | 0.00% | +100.0% |
Q4 2013 | $4,333,000 | +10.3% | 624,586 | -1.8% | 0.00% | 0.0% |
Q3 2013 | $3,929,000 | -3.0% | 635,986 | 0.0% | 0.00% | -33.3% |
Q2 2013 | $4,051,000 | -22.9% | 635,986 | +27.7% | 0.00% | 0.0% |
Q1 2013 | $5,255,000 | -34.4% | 498,001 | 0.0% | 0.00% | -40.0% |
Q3 2012 | $8,007,000 | +25.8% | 498,001 | 0.0% | 0.01% | 0.0% |
Q2 2012 | $6,365,000 | – | 498,001 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syntal Capital Partners, LLC | 17,540 | $167,000 | 0.12% |